Skip to main content

Research summary

Research Hub

Oxytocin

Clinical10 studies

Oxytocin is a neuropeptide hormone studied extensively for its role in social cognition, emotional processing, and neural signaling.

Being studied for

  • Social cognition research
  • Emotional processing pathways
  • Neurobehavioral signaling

Published Research

Evidence profile

Controlled human evidence

10 cited publications · 2 primary trials

Findings below belong to the studies that reported them. They describe the material and conditions those authors used, not this product, and not an outcome to expect.

Supporting evidence

ClinicalPrimary trial

Impact of chronic intranasal oxytocin administration on face expression processing in autistic children: a randomized controlled trial using fMRI

Moerkerke M et al. · Molecular autism · 2024

The study reportedThese findings suggest an attenuating effect of multiple-dose oxytocin administration on neural face processing, potentially supporting the anxiolytic account of oxytocin.

PMID 39709442DOI 10.1186/s13229-024-00635-zView on PubMed
ClinicalPrimary trial

A randomized controlled trial examining the effects of intranasal oxytocin on alcohol craving and intimate partner aggression among couples

Flanagan JC et al. · Journal of psychiatric research · 2022

The study reportedFindings suggest that a single dose of intranasal oxytocin was not efficacious in mitigating alcohol craving or aggression in this sample. Although hypotheses were not supported, the findings provide important evidence that oxytocin was not aggressogenic in this high-risk sample.

PMID 35709548DOI 10.1016/j.jpsychires.2022.06.011View on PubMed
ReviewMeta-analysis

High- vs low-dose oxytocin protocols for labor induction: a systematic review and meta-analysis

Grasch JL et al. · American journal of obstetrics & gynecology MFM · 2025

The study reportedA synthesis of the existing literature demonstrates no difference in the frequency of cesarean delivery following induction of labor using a high- vs low-dose oxytocin protocol.

PMID 40334983DOI 10.1016/j.ajogmf.2025.101691View on PubMed
ReviewMeta-analysis

Reduced risk of cesarean delivery with oxytocin discontinuation in active labor: a systematic review and meta-analysis

Whitley J et al. · American journal of obstetrics and gynecology · 2025

The study reportedAlthough associated with an extension of labor by half an hour, discontinuation of oxytocin in the active phase of labor was associated with a 20% decreased risk of cesarean delivery and a lower risk of uterine tachysystole and nonreassuring fetal heart rate tracing.

PMID 40113155DOI 10.1016/j.ajog.2025.03.015View on PubMed
ReviewMeta-analysis

Oxytocin and vaginal dinoprostone in labor induction: A systematic review and meta-analysis

Chang TA et al. · International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2024

The study reportedWhen amalgamating the available literature, it implies that oxytocin was found to have similar effects as PGE2 on delivery outcomes and safety concerns in pregnant women with GA ≥36 weeks. Although the uterine cervix was unfavorable, both low and high doses of oxytocin were feasible for IOL.

PMID 38404054DOI 10.1002/ijgo.15443View on PubMed
ReviewMeta-analysis

Association of oxytocin augmentation with postpartum hemorrhage: a systematic review and meta-analysis

Jafarabady K et al. · The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2024

The study reportedThis meta-analysis suggests that using oxytocin for labor augmentation is linked to a significant increase in the risk of PPH. It highlights the need for careful monitoring and consideration when using oxytocin, especially in low and middle-income countries where guidelines and supervision are crucial.

PMID 38910114DOI 10.1080/14767058.2024.2369210View on PubMed
ReviewMeta-analysis

Which approach is better for labor induction: simultaneous or sequential administration of oxytocin and intrauterine balloon-a systematic review and a meta-analysis

Chen Q et al. · The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2024

The study reportedThese findings provide support for the simultaneous use of intrauterine balloons and oxytocin during labor induction in nulliparous women. Additionally, this approach may also prove beneficial for multiparas.

PMID 39209533DOI 10.1080/14767058.2024.2395490View on PubMed
ReviewMeta-analysis

The efficacy of intranasal oxytocin in patients with Prader-Willi syndrome: A systematic review and meta-analysis

Shalma NM et al. · Diabetes & metabolic syndrome · 2023

The study reportedOxytocin didn't have significant effects on hyperphagia or weight. To establish the impact of oxytocin in Prader-Willi patients, additional prospective, large-sample randomized controlled trials (RCTs) are needed to avoid controversy.

PMID 36774885DOI 10.1016/j.dsx.2023.102711View on PubMed
ReviewMeta-analysis

Efficacy of oxytocics on reducing intraoperative blood loss during abdominal myomectomy: A systematic review and meta-analysis of randomized placebo-controlled trials

Albazee E et al. · Journal of gynecology obstetrics and human reproduction · 2022

The study reportedAmong women undergoing abdominal myomectomy, administration of oxytocin and carbetocin correlated with several beneficial clinical outcomes, such as reduced intraoperative blood loss, hospital stay, and blood transfusion requirement.

PMID 35314367DOI 10.1016/j.jogoh.2022.102358View on PubMed
ReviewMeta-analysis

Effect of intra-partum Oxytocin on neonatal encephalopathy: a systematic review and meta-analysis

Burgod C et al. · BMC pregnancy and childbirth · 2021

The study reportedIntra-partum Oxytocin may increase the risk of neonatal encephalopathy. Future clinical trials of uterotonics should include neonatal encephalopathy as a key outcome.

PMID 34717571DOI 10.1186/s12884-021-04216-3View on PubMed

Published studies summarised here concern the specific investigational or pharmaceutical materials and study conditions described by their authors. Their findings are not performance claims for Cobalt Peptides material. Citations verified against PubMed on 2026-08-09.

Notice

All information on this page is provided strictly for laboratory research and educational purposes only.